Antifungal Agents Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global antifungal agents market is anticipated to grow at a considerable CAGR of nearly 3.5% during the forecast period (2021-2027). The factor contributing to the growth of antifungal agents include the rise in the number of COVID-19 cases and diabetic patients. Moreover, due to COVID-19, there is an increase in the number of viral infections and bacteria’s which is causing fungal infections, and patients are at high risk of healthcare-associated infections including candidemia or bloodstream infections caused by Candida. Diabetic patients are at more risk of getting affected by black fungus infection which is also known as Mucormycosis.
To Request a Sample of our Report on Antifungal Agents
Market: https://www.omrglobal.com/request-sample/antifungal-agents-market
In addition, the companies are strategically
increasing their product portfolios to grow in the market. For instance, in
April 2021, Pfizer acquired Amplyx Pharmaceuticals, Inc. which is a
privately-held company working in the development of therapies for debilitating
and life-threatening diseases that affect people with compromised immune
systems. Fosmnaogepix (APX001) is Amplyx lead compound and is a novel
asset that is under development for the treatment of invasive fungal
infections. Accordingly, infectious disease is responsible for more than 8.4
million mortalities annually, globally.
Furthermore, In January 2019, Mayne Pharma Group
Ltd. launched TOLSURA (SUBa - itraconazole) 65 mg capsule in the US. TOLSURA is
a formulation of itraconazole for the treatment of fungal infection including
blastomycosis, histoplasmosis, and aspergillosis. These infections commonly
occur in immunocompromised patients such as patients with a history of cancer,
transplants, and HIV/AIDS. The company received approval for TOLSURA in
2018, from the US Food and Drug Administration (FDA). Additionally, in November
2019, SCYNEXIS, Inc. developed Ibrexafungerp for the treatment of Candida Auris
and other difficult-to-treat fungal infections. Thus, the mergers &
acquisitions, partnerships and collaborations and new and innovative product
development in the antifungal agents are driving the growth of the market
during the forecast period.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Drug Class
·
By Dosage Type
·
By Route of Administration
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape-
(Get 15% Discount on Buying this Report)
A
full Report of Antifungal Agents Market is Available @ https://www.omrglobal.com/industry-reports/antifungal-agents-market
Global Antifungal agents Market Report Segment
By Drug Class
·
Polyene
·
Echinocandins
·
Allylamines
·
Azole
By Drug Dosage
·
Powder
·
Ointment
·
Drugs
By Route of Administration
·
Parenteral
·
Topical
·
Oral
Global Antifungal agents Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Company Profiles
·
Abbott Laboratories, Inc.
·
Astellas Pharma Inc.
·
Basilea Pharmaceutica Ltd.
·
Bayer Healthcare LLC
·
Bristol-Myers Squibb Co.
·
Cadila Healthcare Ltd.
·
Cosmo Pharmaceuticals N.V.
·
Dr. Reddy’s Laboratories Ltd.
·
Gilead Sciences, Inc.
·
Janssen Pharmaceutica NV
·
Mayne Pharma Group Ltd.
·
Merck & Co., Inc.
·
Pfizer Inc.
·
Sanofi-Aventis Groupe SA
·
SCYNEXIS, Inc.
·
Sumitomo Dainippon Pharma Co., Ltd.
·
Sun Pharmaceutical Industries Ltd.
·
Teva Pharmaceutical Industries Ltd.
·
Viatris Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment